Guangquan Liu
123 MoChou Road
Nanjing, 210004, China
Nanjing, 210004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Serum metabolic fingerprinting for diagnosis and therapeutic applications of ovarian endometriosis.
Journal: iScience
Published: August 06, 2025
A new risk algorithm combining D-dimer and HE4 differentiates borderline tumor from patients with ovarian tumor.
Journal: Translational cancer research
Published: July 23, 2024
Engineering extracellular vesicles mimetics for targeted chemotherapy of drug-resistant ovary cancer.
Journal: Nanomedicine (London, England)
Published: December 07, 2023
LncRNA IDH1-AS1 sponges miR-518c-5p to suppress proliferation of epithelial ovarian cancer cell by targeting RMB47.
Journal: Journal of biomedical research
Published: November 19, 2023
Function of homocysteine and HE4 in endometrial carcinoma: verified by prospective experiment.
Journal: Translational cancer research
Published: August 28, 2023
New use of preoperative fibrinogen in ovarian cancer management.
Journal: Translational cancer research
Published: May 26, 2023
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer.
Journal: Journal of ovarian research
Published: October 15, 2021
Peptidome characterization of ovarian cancer serum and the identification of tumor suppressive peptide ZYX36-58.
Journal: Annals of translational medicine
Published: September 21, 2020
LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
Journal: Journal of cellular and molecular medicine
Published: July 05, 2020
Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.
Journal: Archives of gynecology and obstetrics
Published: May 07, 2020
A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge.
Journal: Technology in cancer research & treatment
Published: March 14, 2020
LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: March 21, 2019
Last Updated: 09/26/2026